Forschung
Publikationen

Publikationen am BMWZ


Zeige Ergebnisse 1 - 10 von 195
1 2 3 4 5 6 7 Last

2022


Fritsch, S., Gasser, V., Peukert, C., Pinkert, L., Kuhn, L., Perraud, Q., Normant, V., Brönstrup, M., & Schalk, I. J. (2022). Uptake Mechanisms and Regulatory Responses to MECAM- and DOTAM-Based Artificial Siderophores and Their Antibiotic Conjugates in Pseudomonas aeruginosa. ACS infectious diseases, 8(6), 1134-1146.

doi.org/10.1021/acsinfecdis.2c00049

Hotop, S. K., Reimering, S., Shekhar, A., Asgari, E., Beutling, U., Dahlke, C., Fathi, A., Khan, F., Lütgehetmann, M., Ballmann, R., Gerstner, A., Tegge, W., Cicin-Sain, L., Bilitewski, U., McHardy, A. C., & Brönstrup, M. (2022). Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2. Emerging Microbes and Infections, 11(1), 1037-1048.

doi.org/10.1080/22221751.2022.2057874

Napolitano, V., Dabrowska, A., Schorpp, K., Mourão, A., Barreto-Duran, E., Benedyk, M., Botwina, P., Brandner, S., Bostock, M., Chykunova, Y., Czarna, A., Dubin, G., Fröhlich, T., Hölscher, M., Jedrysik, M., Matsuda, A., Owczarek, K., Pachota, M., Plettenburg, O., ... Pyrc, K. (2022). Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chemical Biology, 29(5), 774-784.

doi.org/10.1016/j.chembiol.2021.11.006

Yin, H., Karayel, O., Chao, Y. Y., Seeholzer, T., Hamp, I., Plettenburg, O., Gehring, T., Zielinski, C., Mann, M., & Krappmann, D. (2022). A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. Cellular and Molecular Life Sciences, 79(2), [112].

doi.org/10.1007/s00018-022-04154-z


2021


Arisetti, N., Fuchs, H. L. S., Coetzee, J., Orozco, M., Ruppelt, D., Bauer, A., Heimann, D., Kuhnert, E., Bhamidimarri, S. P., Bafna, J. A., Hinkelmann, B., Eckel, K., Sieber, S. A., Müller, P. P., Herrmann, J., Müller, R., Winterhalter, M., Steinem, C., & Brönstrup, M. (2021). Total synthesis and mechanism of action of the antibiotic armeniaspirol A. Chemical science, 12(48), 16023-16034.

doi.org/10.1039/d1sc04290d

Becker, K., Pfütze, S., Kuhnert, E., Cox, R. J., Stadler, M., & Surup, F. (2021). Hybridorubrins A-D: Azaphilone Heterodimers from Stromata of Hypoxylon fragiforme and Insights into the Biosynthetic Machinery for Azaphilone Diversification. Chemistry - A European Journal, 27(4), 1438-1450.

doi.org/10.1002/chem.202003215

Eggert, A., Etling, C., Millbrodt, L., Schulz, G., & Kalesse, M. (2021). Oxazaborolidinone-Mediated Asymmetric Bisvinylogous Mukaiyama Aldol Reaction. Organic letters, 23(22), 8722-8726.

doi.org/10.1021/acs.orglett.1c03165

Gerckens, M., Schorpp, K., Pelizza, F., Wögrath, M., Reichau, K., Ma, H., Dworsky, A. M., Sengupta, A., Stoleriu, M. G., Heinzelmann, K., Merl-Pham, J., Irmler, M., Alsafadi, H. N., Trenkenschuh, E., Sarnova, L., Jirouskova, M., Frieß, W., Hauck, S. M., Beckers, J., ... Burgstaller, G. (2021). Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics. Science advances, 7(52), [eabb3673].

doi.org/10.1126/sciadv.abb3673

Hamp, I., O’Neill, T. J., Plettenburg, O., & Krappmann, D. (2021). A patent review of MALT1 inhibitors (2013-present). Expert Opinion on Therapeutic Patents, 31(12), 1079-1096.

doi.org/10.1080/13543776.2021.1951703

Kahlert, L., Bernardi, D., Hauser, M., Ióca, L. P., Berlinck, R. G. S., Skellam, E. J., & Cox, R. J. (2021). Early Oxidative Transformations During the Biosynthesis of Terrein and Related Natural Products. Chemistry – A European Journal, 27(46), 11895-11903.

doi.org/10.1002/chem.202101447


Zeige Ergebnisse 1 - 10 von 195
1 2 3 4 5 6 7 Last